On November 5, the US Food and Drug Administration (FDA) updated the labels for all glucagon-like…
Continue ReadingTag: FDA
Progress Made for Gastric Cancer with FDA Approval of Tevimbra
The FDA has approved Tevimbra (tislelizumab-jsgr) for a second indication: in combination with platinum and fluoropyrimidine-based…
Continue Reading
Roche receives FDA approval for the first companion diagnostic to identify patients with gastric and gastroesophageal junction cancer eligible for targeted treatment with VYLOY | News
The new VENTANA CLDN18 (43-14A) RxDx Assay helps fulfil an unmet medical need by enabling clinicians…
Continue Reading
FDA Approves First-in-Class Drug for Gastric Cancer
The FDA has approved Vyloy (zolbetuximab-clzb) as a first-line treatment of adults with locally advanced unresectable…
Continue Reading
RNT Health Insights Private Limited Receives FDA Breakthrough Device Designation for Early Gastric Cancer Detection Tool
ANI | Updated: May 31, 2024 17:42 IST BusinessWire IndiaChandigarh [India], May 31: RNT Health Insights…
Continue Reading